范 羿,周 宇,高 伟.穿心莲内酯通过抑制PI3K/AKT通路对人肝癌HEPG2细胞凋亡的影响[J].肿瘤学杂志,2020,26(6):496-500.
穿心莲内酯通过抑制PI3K/AKT通路对人肝癌HEPG2细胞凋亡的影响
Effect of Andrographolide on Apoptosis of Human Hepatoma HepG2 Cells by Inhibiting PI3K/AKT Pathway
投稿时间:2019-08-14  
DOI:10.11735/j.issn.1671-170X.2020.06.B006
中文关键词:  穿心莲内酯  HEPG2细胞  PI3K/AKT通路  细胞凋亡  细胞增殖
英文关键词:andrographolide  HEPG2 cells  PI3K/AKT pathway  apoptosis  cell proliferation
基金项目:
作者单位
范 羿 雅安市第二人民医院 
周 宇 雅安市第二人民医院 
高 伟 雅安市第二人民医院 
摘要点击次数: 1346
全文下载次数: 291
中文摘要:
      摘 要:[目的] 探讨穿心莲内酯通过抑制磷脂酰肌醇3-激酶(PI3K)/蛋白激酶 B(AKT)通路对人肝癌细胞凋亡的影响。[方法] 将人肝癌细胞株HEPG2分为对照组、低浓度穿心莲内酯组、中浓度穿心莲内酯组、高浓度穿心莲内酯组,低、中、高浓度穿心莲内酯组分别加入培养基稀释的终浓度为10、30、50 μmol/L的穿心莲内酯,对照组加入等剂量的培养基。采用四甲基偶氮唑盐(MTT)法检测各组HEPG2细胞增殖率,流式细胞术检测各组HEPG2细胞凋亡率,Western blot法检测各组HEPG2细胞PI3K、p-AKT蛋白表达水平。[结果]低浓度穿心莲内酯组HEPG2细胞增殖率及PI3K、p-AKT蛋白表达水平较对照组明显下降(Q=2.942、9.836、6.348,P<0.05);中浓度穿心莲内酯组HEPG2细胞增殖率及PI3K、p-AKT蛋白表达水平较低浓度穿心莲内酯组明显下降(Q=2.942、13.832、10.691,P<0.05);高浓度穿心莲内酯组HEPG2细胞增殖率及PI3K、p-AKT蛋白表达水平较中浓度穿心莲内酯组明显下降(Q=13.411、19.058、16.371,P<0.05)。低浓度穿心莲内酯组HEPG2细胞凋亡率较对照组明显升高(Q=83.662,P<0.05);中浓度穿心莲内酯组HEPG2细胞凋亡率较低浓度穿心莲内酯组明显升高(Q=147.267,P<0.05);高浓度穿心莲内酯组HEPG2细胞凋亡率较中浓度穿心莲内酯组明显升高(Q=241.925,P<0.05)。[结论] 穿心莲内酯可能通过抑制PI3K/AKT通路抑制人肝癌细胞增殖,促进人肝癌细胞凋亡,可为临床治疗肝癌提供新方向。
英文摘要:
      Abstract:[Objective] To investigate the effect of andrographolide on apoptosis of human hepatoma HepG2 cells and its relation with phosphatidylinositol 3-kinase(PI3K)/protein kinase B(AKT) pathway. [Methods] Human hepatoma HepG2 cells were divided into control group,low andrographolide concentration group(10 μmol/L),medium andrographolide concentration group(30 μmol/L) and high andrographolide concentration group(50 μmol/L). The proliferation rate of HEPG2 cells was detected by MTT,the apoptosis rate of HEPG2 cells was detected by flow cytometry,and the expression levels of PI3K and p-AKT protein in HEPG2 cells were detected by Western blot. [Results] The proliferation rate and the expression of PI3K and p-AKT protein in the control group were higher than those in low,medium and high andrographolide groups(Q=2.942,9.836,6.348,P<0.05;Q=2.942,13.832,10.691,P<0.05 and Q=13.411,19.058,16.371,P<0.05). The apoptosis rate of HEPG2 cells in control group was lower than that in low,medium and high andrographolide groups(Q=83.662,P<0.05,Q=147.267,P<0.05 and Q=241.925,P<0.05). [Conclusion] Andrographolide may inhibit the proliferation and promote the apoptosis of human hepatocellular carcinoma HepG2 cells by inhibiting PI3K/AKT pathway,and also promote the apoptosis of HepG2 cells,which may provide a new direction for clinical treatment of hepatocellular carcinoma.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器